| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7595021 | SAGE PRODS | Method of providing alcohol-free disinfection |
May, 2023
(4 months ago) | |
| US7066916 | SAGE PRODS | Disinfectant delivery system, and method of providing alcohol-free disinfection |
Feb, 2024
(4 months from now) | |
| US7717889 | SAGE PRODS | Disinfectant delivery system and method of providing alcohol free disinfection |
Feb, 2025
(1 year, 4 months from now) | |
| US7427574 | SAGE PRODS | Non-woven wash cloth |
Apr, 2026
(2 years from now) | |
| US7935093 | SAGE PRODS | Disinfectant delivery system and method of providing alcohol-free disinfection |
Oct, 2027
(4 years from now) | |
Chlorhexidine Gluconate is owned by Sage Prods.
Chlorhexidine Gluconate contains Chlorhexidine Gluconate.
Chlorhexidine Gluconate has a total of 5 drug patents out of which 1 drug patent has expired.
Expired drug patents of Chlorhexidine Gluconate are:
- US7595021
Chlorhexidine Gluconate was authorised for market use on 25 April, 2005.
Chlorhexidine Gluconate is available in cloth;topical dosage forms.
Chlorhexidine Gluconate can be used as for the preparation of skin prior to surgery; helps reduce bacteria that can potentially cause skin infection, disinfection of patient skin prior to an invasive procedure.
The generics of Chlorhexidine Gluconate are possible to be released after 02 October, 2027.
Drugs and Companies using CHLORHEXIDINE GLUCONATE ingredient
Market Authorisation Date: 25 April, 2005
Treatment: For the preparation of skin prior to surgery; Helps reduce bacteria that can potentially cause skin infection; Disinfection of patient skin prior to an invasive procedure
Dosage: CLOTH;TOPICAL
CHLORHEXIDINE GLUCONATE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic